Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-14.57%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-14.57%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-176.20%
Never
—
—
Never
—
5 Years
Score—
Net Growth-176.20%
Net TrendNever
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
DiaMedica Therapeutics Inc fundamental performance
Across DiaMedica Therapeutics Inc's full reported history, from 2008 to 2025, net income went from -$ 1M to -$ 32M. Revenue increased in 6% of the years measured; net income in 17%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 6.84 | — |
1 Year2025-08-12 | $ 5.22 | 31.03% |
5 Years2021-08-12 | $ 3.21 | 113.08% |
10 Years2016-08-12 | $ 3.60 | 90.21% |
All Time2008-01-04 | $ 1.30 | 426.64% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2008-01-04 |
|---|---|---|---|---|---|
| Price | $ 6.84 | $ 5.22 | $ 3.21 | $ 3.60 | $ 1.30 |
| Return | — | 31.03% | 113.08% | 90.21% | 426.64% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | -$ 28K | -$ 37M | $ 43M |
| 2025 | $ 0.00 | -$ 32M | $ 59M |
| 2024 | $ 0.00 | -$ 24M | $ 44M |
| 2023 | $ 0.00 | -$ 19M | $ 52M |
| 2022 | $ 0.00 | -$ 13M | $ 33M |
| 2021 | $ 0.00 | -$ 13M | $ 45M |
| 2020 | $ 0.00 | -$ 12M | $ 27M |
| 2019 | $ 0.00 | -$ 10M | $ 7M |
| 2018 | $ 500K | -$ 5M | $ 16M |
| 2017 | $ 0.00 | -$ 4M | $ 1M |
| 2016 | $ 0.00 | -$ 2M | $ 1M |
| 2015 | $ 0.00 | -$ 1M | $ 165.69K |
| 2014 | $ 0.00 | -$ 4M | $ 203.78K |
| 2013 | $ 0.00 | -$ 7M | $ 2M |
| 2012 | $ 0.00 | -$ 10M | $ 2M |
| 2011 | $ 0.00 | -$ 6M | $ 2M |
| 2010 | $ 0.00 | -$ 4M | $ 2M |
| 2009 | -$ 2M | $ 629.53K | |
| IPO2008 | -$ 1M | $ 2M |
Explore beyond DMAC
You're looking at DiaMedica Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
